Automation index

How much of a Production engineer’s job can AI already do?

An OEE and a sequencer come earlier. Getting the shift out without stopping the line for nothing do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

25%

AI can already do 25% of this job.

#233 / 633

Production engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
OEE, sequence and the shift plan. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Line, changeovers and the micro-stop. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Layout, times and the work standard. Estimate No public source provides a precise figure. This is our estimate.	16%	36%	+5.8
Supervisors, unions and the shift that turns. Estimate No public source provides a precise figure. This is our estimate.	16%	18%	+2.9
In-line quality and the batch that cannot ship. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Hit the plan, and not dressing the OEE. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		25%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 633

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low